from lessons learned


Ahern, J., Stuber, J., & Galea, S. (2007).
Stigma, discrimination and the health of illicit drug users. Drug and Alcohol Dependence, 88(2-3), 188–96. doi:10.1016/j.drugalcdep.2006.10.014


Corazza, O., Simonato, P., Corkery, J., Trincas, G., & Schifano, F.
“Legal highs”: safe and legal “heavens”? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK. Rivista Di Psichiatria, 49(2), 89–94. doi:10.1708/1461.16147


DeLoache, W. C., Russ, Z. N., Narcross, L., Gonzales, A. M., Martin, V. J. J., & Dueber, J. E. (2015).
An enzyme-coupled biosensor enables (S)-reticuline production in yeast from glucose. Nature Chemical Biology. doi:10.1038/nchembio.1816


EMCDDA. (2015).
New psychoactive substances in Europe : An update from the EU Early Warning System. Luxembourg. Doi:10.2810/372415


Erickson, P.G., Adlaf, E.M., Smart, R.G. and Murray, G. F. (1994).
The Steel Drug. Cocaine and Crack in Perspective, Lexington Books, New York, NY. - Cerca con Google. (N. Lexington Books, New York, Ed.).


Ferrence, R. (2001).
Diffusion theory and drug use. Addiction (Abingdon, England), 96(1), 165–73. doi:10.1080/09652140020017030


Fossati, E., Narcross, L., Ekins, A., Falgueyret, J.-P., & Martin, V. J. J. (2015).
Synthesis of Morphinan Alkaloids in Saccharomyces cerevisiae. PloS One, 10(4), e0124459. doi:10.1371/journal.pone.0124459


Fountoulakis, K. N., & Theodorakis, P. N. (2014).
Austerity and health in Greece. Lancet, 383(9928), 1543. doi:10.1016/S0140-6736(14)60739-X


Galanie, S., Thodey, K., Trenchard, I. J., Filsinger Interrante, M., & Smolke, C. D. (2015).
Complete biosynthesis of opioids in yeast. Science, 349(6252), 1095–1100. doi:10.1126/science.aac9373


Giné, C. V., Espinosa, I. F., & Vilamala, M. V.
New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon? Drug Testing and Analysis, 6(7-8), 819–24. doi:10.1002/dta.1610


Grund, J., Coffin, P., Jauffret-roustide, M., Dijkstra, M., Bruin, D. De, & Bruin, D. de. (2010).
The fast and furious — cocaine , amphetamines and harm reduction. Harm Reduction: Evidence, Impacts and Challenges, 191–232. Retrieved from


Grund, J. P., Adriaans, N. F., & Kaplan, C. D. (1991).
Changing cocaine smoking rituals in the Dutch heroin addict population. British Journal of Addiction, 86(4), 439–448.


Grund, J. P., Blanken, P., Kaplan, C. D., Verveen, J., Hartgers, C., Van Den Hoek, J. A., & Leenders, F. (1992).
The relationship between Dutch drug policy and injecting drug use: current injecting and heroin use onset date. IntConfAIDS, 8, D400.


Grund, J.-P. C., & Blanken, P. (1993).
From “Chasing the Dragon” to “Chinezen”: the Diffusion of Heroin Smoking in the Netherlands. Addiction Research Institute (IVO), Rotterdam. Retrieved from


Grund, J.-P. C., Vavrincikova, L., Janikova, B., Fidesova, H., & Miovsky, M. (2016).
The Emperor’s New Clothes? Highlights from the Rapid Assessment & Response Study of New Psychoactive Drugs in five EU Member States. Adiktologie.


Grund J-PC. (2015).
Technology & Drugs. The End of Drug Policy as We Know It? Presented in parallel Session 54, “Internet, Unternet & Harm Reduction,” International Harm Reduction Conference, Kuala Lumpur, 21-10-2015.


Hedrich, D., Kalamara, E., Sfetcu, O., Pharris, A., Noor, A., Wiessing, L., … de laar, M. Van. (2013).
Human immunodeficiency virus among people who inject drugs: Is risk increasing in Europe? EUROSURVEILLANCE, 18(48), 7–12. Retrieved from


Janikova, B., Fidesova, H., Vavrincikova, L., Miovsky, M., & Grund, J.-P. C. (2016).
New Psychoactive Substances among People Who Use Drugs Heavily in Europe: Novel Drugs, Vintage Problems & Responses. Adiktologie.


Katz, E., Levin, M. L., & Hamilton, H. (1963).
Traditions of Research on the Diffusion of Innovation. American Sociological Review, 28(2), 237–252. doi:10.2307/2090611


Kentikelenis, A., Karanikolos, M., Reeves, A., McKee, M., & Stuckler, D. (2014).
Greece’s health crisis: from austerity to denialism. Lancet, 383(9918), 748–53. doi:10.1016/S0140-6736(13)62291-6


Kwasniewski, A. (2012). Saying No to Costly Drug Laws. The New York Times, Opinion Pages, May 10, 2012.


Merton, R. K. (1936).
The Unanticipated Consequences of Purposive Social Action. American Sociological Review, 1(6), 894-904.


Myers, R. (2008).
Responding to the Time-Based Failures of the Criminal Law Through a Criminal Sunset Amendment. Retrieved from


Parker, H., Newcombe, R., & Bakx, K. (1987).
The New Heroin Users: prevalence and characteristics in Wirral, Merseyside. Addiction, 82(2), 147–157. doi:10.1111/j.1360-0443.1987.tb01453.x


Péterfi, A., Tarján, A., Horváth, G. C., Csesztregi, T., & Nyírády, A. (2014).
Changes in patterns of injecting drug use in Hungary: a shift to synthetic cathinones. Drug Testing and Analysis, 6(7-8), 825–31. doi:10.1002/dta.1625


Power, M. (2013).
Drugs 2.0: The Web Revolution That’s Changing How the World Gets High. Portobello Books Ltd. Retrieved October 22, 2014, from


Rogers, E. M. (2003).
Diffusion of Innovations 5th ed. New York NY Free Press. Free Press. Retrieved from


Tarján, A., Dudás, M., Gyarmathy, V. A., Rusvai, E., Tresó, B., & Csohán, Á. (2015).
Emerging Risks Due to New Injecting Patterns in Hungary During Austerity Times. Substance Use & Misuse, 1–11. doi:10.3109/10826084.2015.978672


TNS Political & Social. (2014)
Flash Eurobarometer 401 Young People And Drugs Report.


Travis, A. (2016).
Ban on legal highs delayed over concerns law is not enforceable. The Guardian.


UNODC. (2013).
The Challenge of New Psychoactive Substances. Vienna. Retrieved from


Westermeyer, J. (1976).
The pro-heroin effects of anti-opium laws in Asia. Archives of General Psychiatry, 33(9), 1135–9. Retrieved from


Zamengo, L., Frison, G., Bettin, C., & Sciarrone, R. (2014).
Understanding the risks associated with the use of new psychoactive substances (NPS): high variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products. Toxicology Letters, 229(1), 220–8. doi:10.1016/j.toxlet.2014.06.012


Zirpel, B., Stehle, F., & Kayser, O. (2015).
Production of 9-tetrahydrocannabinolic acid from cannabigerolic acid by whole cells of Pichia (Komagataella) pastoris expressing 9-tetrahydrocannabinolic acid synthase from Cannabis sativa L. Biotechnology Letters, 37(9), 1869–75. doi:10.1007/s10529-015-1853-x





Defining NPS

New to Whom?

UNODC defines new psychoactive substancesor NPS as:... read more


Defining Target Groups

Defining the Project’s target audience or end beneficiaries comes with considerable difficulties. The official project title... read more





Project News

nps mini

Addictology, the Czech based journal for research into addiction, published a special issue on NPS related articles, including those with the outcomes of the NPS in Europe project.

nps mini

The NPS staff presented project outcomes at the International Harm Reduction Conference in Kuala Lumpur, Malaysia.

nps mini
NPS Policy: Moving Forward
Leading European experts, including researchers, practitioners and policy makers will meet at a Seminar in Lisbon on the 26th of November to discuss the latest developments in the field of New Psychoactive Substances (NPS).

nps mini
The NPS in Europe project organises a training on new psychoactive substances (nps), 23 - 25 November 2015 in Lisbon, Portugal. The training is aimed at service provider and peers, supporting NPS users in Europe. The course will give an overview of relevant NPS substances, identify current patterns and develop effective harm reduction service responses.
read more..

Practical information...

nps mini
NPS in Europe

is launching a questionnaire on NPS use in all European countries.